(UroToday.com) In plenary program of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Fleming discussed treatment sequencing in advanced prostate cancer within a session entitled “Beyond the Androgen Receptor: New Avengers in the Treatment of Castrate-Resistant Metastatic Cancer”.